Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alain Astier

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
Fundamental & Clinical Pharmacology|October 13, 2009
No effect of CYP450 and P-glycoprotein on hydroxyurea in vitro metabolismHind Sassi, Dora Bachir, Anoosha Habibi, et al.
European Journal of Hospital Pharmacy : Science and Practice|June 4, 2019
Implementation of automated dispensing cabinets for management of medical devices in an intensive care unit: organisational and financial impactElsa Bourcier, Sophie Madelaine, Valérie Archer, et al.
Fundamental & Clinical Pharmacology|April 1, 2006
Distribution of calcineurin activity in blood cell fractions and impact of tacrolimus inhibitionBenoit Blanchet, Anne Hulin, Bijan Ghaleh, et al.
International Journal of Pharmaceutics|March 8, 2013
Long-term physico-chemical stability of diluted trastuzumabMuriel Paul, Victoire Vieillard, Ricardo Da Silva Lemos, et al.
European Journal of Cancer (Oxford, England : 1990)|February 29, 2016
Stability of ipilimumab in its original vial after opening allows its use for at least 4 weeks and facilitates pooling of residuesPascale Bardo-Brouard, Victoire Vieillard, Tala Shekarian, et al.
European Journal of Cancer (Oxford, England : 1990)|June 1, 2014
Therapeutic drug monitoring in cancer--are we missing a trick?Christophe Bardin, Gareth Veal, Angelo Paci, et al.
European Journal of Cancer (Oxford, England : 1990)|June 4, 2014
Review of therapeutic drug monitoring of anticancer drugs part 1--cytotoxicsAngelo Paci, Gareth Veal, Christophe Bardin, et al.
European Journal of Cancer (Oxford, England : 1990)|June 15, 2014
Review of therapeutic drug monitoring of anticancer drugs part two--targeted therapiesNicolas Widmer, Christophe Bardin, Etienne Chatelut, et al.
Pharmaceuticals (Basel, Switzerland)|December 28, 2021
Simple Approach to Enhance Green Tea Epigallocatechin Gallate Stability in Aqueous Solutions and Bioavailability: Experimental and Theoretical CharacterizationsPhilippe-Henri Secretan, Olivier Thirion, Hassane Sadou Yayé, et al.
Hemoglobin|November 13, 2007
Plasma and urine hydroxyurea levels might be useful in the management of adult sickle cell diseaseDora Bachir, Anne Hulin, Estelle Huet, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Fundamental & Clinical Pharmacology|October 13, 2009
No effect of CYP450 and P-glycoprotein on hydroxyurea in vitro metabolismHind Sassi, Dora Bachir, Anoosha Habibi, et al.
European Journal of Hospital Pharmacy : Science and Practice|June 4, 2019
Implementation of automated dispensing cabinets for management of medical devices in an intensive care unit: organisational and financial impactElsa Bourcier, Sophie Madelaine, Valérie Archer, et al.
Fundamental & Clinical Pharmacology|April 1, 2006
Distribution of calcineurin activity in blood cell fractions and impact of tacrolimus inhibitionBenoit Blanchet, Anne Hulin, Bijan Ghaleh, et al.
International Journal of Pharmaceutics|March 8, 2013
Long-term physico-chemical stability of diluted trastuzumabMuriel Paul, Victoire Vieillard, Ricardo Da Silva Lemos, et al.
European Journal of Cancer (Oxford, England : 1990)|February 29, 2016
Stability of ipilimumab in its original vial after opening allows its use for at least 4 weeks and facilitates pooling of residuesPascale Bardo-Brouard, Victoire Vieillard, Tala Shekarian, et al.
European Journal of Cancer (Oxford, England : 1990)|June 1, 2014
Therapeutic drug monitoring in cancer--are we missing a trick?Christophe Bardin, Gareth Veal, Angelo Paci, et al.
European Journal of Cancer (Oxford, England : 1990)|June 4, 2014
Review of therapeutic drug monitoring of anticancer drugs part 1--cytotoxicsAngelo Paci, Gareth Veal, Christophe Bardin, et al.
European Journal of Cancer (Oxford, England : 1990)|June 15, 2014
Review of therapeutic drug monitoring of anticancer drugs part two--targeted therapiesNicolas Widmer, Christophe Bardin, Etienne Chatelut, et al.
Pharmaceuticals (Basel, Switzerland)|December 28, 2021
Simple Approach to Enhance Green Tea Epigallocatechin Gallate Stability in Aqueous Solutions and Bioavailability: Experimental and Theoretical CharacterizationsPhilippe-Henri Secretan, Olivier Thirion, Hassane Sadou Yayé, et al.
Hemoglobin|November 13, 2007
Plasma and urine hydroxyurea levels might be useful in the management of adult sickle cell diseaseDora Bachir, Anne Hulin, Estelle Huet, et al.
Pageof 4